Suppr超能文献

[通过根除幽门螺杆菌实现溃疡愈合:一周的治疗足够吗?]

[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].

作者信息

Labenz J, Tillenburg B, Peitz U, Köhl H, Becker T, Stolte M, Börsch G

机构信息

Klinik für Innere Medizin und Gastroenterologie, Elisabeth-Krankenhaus, Essen.

出版信息

Dtsch Med Wochenschr. 1996 Jan 5;121(1-2):3-7; discussion 7-8. doi: 10.1055/s-2008-1042964.

Abstract

AIM OF STUDY

To test whether one week's triple therapy with omeprazole and two antibiotics is enough to induce healing of a peptic (gastric and/or duodenal) ulcer.

PATIENTS AND METHODS

112 Patients (73 males, 39 females; median age 55 [18-88] years) proven by culture or histology to have an Helicobacter (H.) pylori infection and uncomplicated peptic (gastroduodenal) ulcer. For one week they received omeprazole (20 mg once or twice daily) plus two antibiotics (clarithromycin/metronidazole, clarithromycin/tetracycline, clarithromycin/amoxycillin or amoxycillin/metronidazole) to eradicate H. pylori. No further anti-ulcer treatment was given subsequently. Healing of the ulcer and H. pylori status were checked by the urease test, culture and histology (endoscopic biopsy) 4 weeks later.

RESULTS

The 5-week ulcer healing rate was 94.6% (95% confidence interval: 89-98%). Persisting ulcers (n = 6) were associated with either treatment with aspirin or nonsteroidal antiinflammatory drugs (n = 3), persistent H. pylori infection (n = 2) or persistent H. pylori infection plus treatment with aspirin (n = 1). The ulcer healing rate was significantly higher in patients with eradicated infection than in those with posttherapy persistence of H. pylori (97.0 vs. 76.9%; P = 0.02). There were no significant differences after 5 weeks between patients with duodenal and those with gastric ulcer (97.4 vs. 89.3%).

CONCLUSIONS

One-week effective eradication treatment is adequate to induce healing of H. pylori-positive peptic ulcers. Anti-ulcer treatment after eradication of H. pylori should be considered only if the patient is receiving treatment with ulcerogenic drugs or continues to have symptoms.

摘要

研究目的

测试奥美拉唑与两种抗生素联合使用一周是否足以促使消化性(胃和/或十二指肠)溃疡愈合。

患者与方法

112例经培养或组织学证实感染幽门螺杆菌且患有无并发症的消化性(胃十二指肠)溃疡的患者(73例男性,39例女性;年龄中位数55[18 - 88]岁)。他们接受了为期一周的奥美拉唑(每日一次或两次,每次20毫克)加两种抗生素(克拉霉素/甲硝唑、克拉霉素/四环素、克拉霉素/阿莫西林或阿莫西林/甲硝唑)治疗以根除幽门螺杆菌。随后未再给予进一步的抗溃疡治疗。4周后通过尿素酶试验、培养和组织学(内镜活检)检查溃疡愈合情况及幽门螺杆菌状态。

结果

5周时溃疡愈合率为94.6%(95%置信区间:89 - 98%)。持续存在的溃疡(n = 6)与阿司匹林或非甾体抗炎药治疗(n = 3)、持续的幽门螺杆菌感染(n = 2)或持续的幽门螺杆菌感染加阿司匹林治疗(n = 1)有关。感染根除的患者溃疡愈合率显著高于幽门螺杆菌治疗后仍持续存在的患者(97.0%对76.9%;P = 0.02)。5周后十二指肠溃疡患者和胃溃疡患者之间无显著差异(97.4%对89.3%)。

结论

为期一周的有效根除治疗足以促使幽门螺杆菌阳性消化性溃疡愈合。仅当患者正在接受致溃疡药物治疗或仍有症状时,才应考虑在根除幽门螺杆菌后进行抗溃疡治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验